Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about NOVARTIS
10/13 NOVARTIS AG (ADR)(NYSE : NVS) Says It Will Not Sell Its Stake In Roche
10/11 NOVARTIS : Foundation launches Healthy Schools for Healthy Communities with the ..
10/10 NOVARTIS : Alcon receives CE Mark for first of its kind AutonoMe preloaded intra..
10/06 NOVARTIS : Alcon receives CE Mark for first-of-its-kind AutonoMe(TM) preloaded i..
10/04 NOVARTIS : KHCC, Novartis Pharma AG sign cooperation agreement
10/04 NOVARTIS : Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Tri..
10/02 NOVARTIS : and UC Berkeley collaborate to tackle 'undruggable' disease targets
10/02 NOVARTIS : Alcon introduces new innovations in cataract surgery at European Soci..
09/28 NOVARTIS : Access and government of Cameroon sign memorandum of understanding to..
09/28 NOVARTIS : forges UC Berkeley pact, sees drug hopefuls in three years
09/28 NOVARTIS : and UC Berkeley collaborate to tackle 'undruggable' disease targets
09/26 NOVARTIS : wins 1st place at the SAMS Europe Award 2017 with "Cloud SAM for Sale..
09/22 NOVARTIS : and The Max Foundation transform pioneering cancer access program for..
09/21 NOVARTIS : New analysis shows Entresto improved physical and social activity in ..
09/20 NOVARTIS : drug Rydapt® (midostaurin) receives EU approval for newly diagnosed F..
More most relevant news
All news about NOVARTIS
10/13 NOVARTIS : Alcon Laboratories, Inc. Constellation LXT Vitrectomy/ Vitreoretinal ..
10/13 NOVARTIS : 65-- Alcon Laboratories, Inc. Constellation LXT Vitrectomy/ Vitreoret..
10/13 NOVARTIS AG (ADR)(NYSE : NVS) Says It Will Not Sell Its Stake In Roche
10/13 NOVARTIS : Alcon Centurion Analyzers (Optometry) | 10/1/17 - 093018 ultimate end..
10/12 NOVARTIS : Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Tri..
10/11 NOVARTIS : Alcon Centurion Analyzers (Optometry) | 10/1/17 - 093018 ultimate end..
10/11 NOVARTIS : J-- Alcon Centurion Analyzers (Optometry) | 10/1/17 - 093018 ultimate..
10/11 NOVARTIS : Foundation launches Healthy Schools for Healthy Communities with the ..
10/11 NOVARTIS : Foundation launches Healthy Schools for Healthy Communities with the ..
10/10 NOVARTIS : Alcon receives CE Mark for first of its kind AutonoMe preloaded intra..
More news
Sector news : Pharmaceuticals - NEC
03:54p Drugmakers Amneal, Impax to combine in generics push
11:09aDJHUTCHISON CHINA MEDITECH : AstraZeneca Say Drug Shows Potential to Treat Lung Ca..
08:48aDJDaimler Charts Leaner Approach -- WSJ
08:46aDJASTRAZENECA : FDA Accepts Imfinzi Supplemental Biologics License Application; Gr..
06:48aDJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
10/16DJALLERGAN : Loses Patent Fight in Federal Court
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
10/16 President Trump at it again with comments on "out of control" drug prices
10/16 SANOFI : Upward Trajectory In 2017
10/14 3 THINGS IN BIOTECH YOU SHOULD LEARN : October 14, 2017
10/13 3 THINGS IN BIOTECH YOU SHOULD LEARN : October 13, 2017
10/11 Hurricane-related damage could cause shortages of 40 drugs - FDA
10/11 BIOTECH ANALYSIS CENTRAL : Daily Pharma News
Latest Tweets
03:15pPharmalot.. Pharmalittle.. Good Morning.. Novartis closing a generic plant &a.. 
01:10pNovartis AG $NVS Set to Announce Earnings on Tuesday  
12:13pForeign Stock Roundup: Roche Gets FDA Nod for Zika Test, Shell to Buy NewMoti.. 
06:50aNovartis to close 450-employee Sandoz plant in Broomfield
2
12:40aDrugmaker Novartis to close 450-employee Sandoz plant in Broomfield
1
More tweets
Qtime:254
Financials ($)
Sales 2017 48 768 M
EBIT 2017 11 713 M
Net income 2017 7 272 M
Debt 2017 17 716 M
Yield 2017 3,29%
P/E ratio 2017 25,59
P/E ratio 2018 21,86
EV / Sales 2017 5,02x
EV / Sales 2018 4,79x
Capitalization 227 B
Chart NOVARTIS
Duration : Period :
Novartis Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Technical analysis trends NOVARTIS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Average target price 87,4 $
Spread / Average Target 0,92%
EPS Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS13.23%226 956
JOHNSON & JOHNSON18.42%365 346
ROCHE HOLDING LTD.5.20%215 359
PFIZER11.88%214 265
MERCK AND COMPANY7.68%172 751
AMGEN25.17%132 728